Lipiodol-TACE With Idarubicin for Hepatocellular Carcinoma
NCT05280444
·
clinicaltrials.gov ↗
PHASE2,PHASE3
Phase
UNKNOWN
Status
216
Enrollment
OTHER
Sponsor class
Conditions
Hepatocellular Carcinoma
Interventions
DRUG:
Idarubicin Hydrochloride for Injection
Sponsor
Zhongda Hospital